Results

Total Results: 259 records

Showing results for "pharmacies".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
    September 02, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Omega-3 Fa…
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension Future Research Needs Paper Number 14 Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor…
  3. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
    February 01, 2022 - Emergency Medical Service/911 Workforce Mental or Behaviorial Health Issues Topic Development Brief Emergency Medical Service/911 Workforce Mental or Behavioral Health Issues Main Point • A new systematic evidence review on Emergency Medical Service/911 workforce mental or behavioral health issues i…
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
    November 07, 2019 - Evidence-based Practice Center Systematic Review Protocol: Management of High-Need, High-Cost Patients: A Realist and Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Management of High-Need, High-Cost Patients: A Realist and Systematic Review I. Background and Obje…
  5. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Layout 1 Background This report evaluates the level of evidence currently available to support the effectiveness and safety of using recombinant activated coagulation factor VII (rFVIIa) for clinical indications not approved by the U. S. Food and Drug Administration (FDA). rFVIIa is approved for a variety of uses i…
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
    September 01, 2015 - Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study Research White Paper Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study Research White Paper Assessing the Predict…
  7. effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
    May 25, 2021 - Adults are also more likely to get their vaccines at alternate places such as at their workplace or at pharmacies
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
    February 01, 2012 - Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults Future Research Needs Paper Number 13 Future Research Needs for First- and Second- Generation Antipsychotics for Children and Young Adults Future Research Needs Paper Number 13 Future Research Needs for F…
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
    January 01, 2013 - care and support services) and organizations (e.g., hospitals, clinics, community health centers, pharmacies
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - organizations (e.g., hospitals, clinics, community health centers, community-based organizations, pharmacies
  11. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - ORIGINAL ARTICLE Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results Sebastian Schneeweiss, MD, ScD,* Amanda R. Patrick, MS,* Til Stürmer, MD, MPH,* M. Alan Brookhart, PhD,* Jerry Avorn, MD,* Malcolm Maclure, ScD,* Kenneth J. Rothman, DM…
  12. effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
    December 29, 2020 - Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatments for Acute Pain: A Systematic Review Draft report available for public comment from August 31, 2020,…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
    March 01, 2012 - Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1007 Published Online: March 2012 …
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population Future Research Needs Paper Number 10 Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population Future Research Needs Paper Number 10 Future Research Needs for Hematopoieti…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
    March 01, 2015 - Public Reporting of Cost Measures in Health An Environmental Scan of Current Practices and Assessment of Consumer Centeredness Technical Brief Number 19 Technical Brief Number 19 Public Reporting of Cost Measures in Health An Environmental Scan of Current Practices and Assessment of Consumer Centeredness…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - vaccine, can be obtained outside of the health care system (a problem not unique to pregnancy) through pharmacies
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - 1 Comparative Effectiveness Review Number 150 Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis Executive Summary Background Multiple sclerosis (MS) is a variably debilitating disease characterized by demyelination (deterioration of the protective myelin sheat…
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - Layout 1 Background Preterm birth is defined as delivery before the completion of the 37th week of gestation, and it affects 13 percent of live births in the United States.1 According to the 2010 National Vital Statistics report, there were 542,893 preterm births in the United States in 2006.2 Rates of preterm birth…
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
    January 01, 2011 - Finding Evidence for Comparing Medical Interventions Methods Guide for Comparative Effectiveness Reviews Finding Evidence for Comparing Medical Interventions Comparative Effectiveness Reviews are systematic reviews of existing research on the effectiveness, comparative effectiveness, an…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=772 Published Online: March 2012 Comparative Effectiveness Research Revie…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: